Colorado BioScience Association (CBSA) announces the 9th BioWest Conference, September 11, 2012, at the Marriott City Center, Denver. The six finalists in the 2012 Venture Showcase competition at BioWest include: Flashback Technologies Inc. - Longmont, CO; KromaTiD - Fort Collins, CO; Siva Therapeutics Inc. - Boulder, CO; Sophono Inc. - Boulder, CO; SuviCa Inc. - Boulder, CO; and VetDC Inc. - Fort Collins, CO.

1.
Colorado BioScience Association Announces 2012 BioWest Conference,
Unveiling Finalists in the Venture Showcase Competition
Colorado BioScience Association (CBSA) announces the 9th BioWest Conference, September 11, 2012, at the
Marriott City Center, Denver. The six finalists in the 2012 Venture Showcase competition at BioWest include:
Flashback Technologies Inc. ‐ Longmont, CO; KromaTiD ‐ Fort Collins, CO; Siva Therapeutics Inc. ‐ Boulder,
CO; Sophono Inc. ‐ Boulder, CO; SuviCa Inc. ‐ Boulder, CO; and VetDC Inc. ‐ Fort Collins, CO.
Denver, CO – July 17, 2012 The Colorado BioScience Association (CBSA) announces the 9th BioWest
Conference, September 11, 2012, at the Marriott City Center, Denver. The announcement is made by CBSA
President & CEO Holli Riebel, who says, “BioWest is the Rocky Mountain region's premier medical device and
biotechnology conference and the venue of our much anticipated Venture Showcase competition. We've now
selected the six finalists for this year's Venture Showcase and are thrilled by the amazing new technologies
that will be presented at BioWest in September."
The six finalists in the 2012 Venture Showcase competition include:
Flashback Technologies Inc. ‐ Longmont, CO ‐ is developing and commercializing product applications of its
proprietary software algorithm platform called CipherSensorTM Technology. The first product application is in the
medical trauma setting enabling the immediate, noninvasive detection of the risk for cardiovascular collapse and
monitoring of the effectiveness of fluid resuscitation therapy. http://www.flashbacktechnologies.com
KromaTiD ‐ Fort Collins, CO ‐ makes products for analyzing defects and damage to human chromosomes. The
company is launching the first commercial platform for the discovery and detection of a recalcitrant class of DNA
mutations known as Chromosomal Inversions. http://www.kromatid.com
Siva Therapeutics Inc. ‐ Boulder, CO ‐ is developing a method for cancer therapy which promises to be safer, with
fewer side effects, and at least as effective as current therapies. The company’s approach is precision photothermal
treatment of solid tumors using targeted gold nanorods ‐ SivaRods™. http://www.sivatherapeutics.com
Sophono Inc. ‐ Boulder, CO ‐ has developed the world’s first non‐percutaneous, implantable, bone‐anchored
hearing device. The company’s Alpha 1 System eliminates the problematic abutment of other devices by using
magnets to securely affix the external sound processor to a titanium implant. http://www.sophono.com
SuviCa Inc. ‐ Boulder, CO ‐ is a biotechnology company focused on the discovery and development of small molecule
drugs for oncology. The company’s family of compounds target a process crucial for cancer growth but under‐
utilized as a drug target. http://www.suvica.com
VetDC Inc. ‐ Fort Collins, CO ‐ is an emergent veterinary biotechnology company that licenses innovative human
biomedical technologies to address serious unmet medical needs in companion animals. The company’s lead
candidate is a novel anti‐cancer drug. http://www.vet‐dc.com
The Venture Showcase finalists pitch their technologies and business plans in front of a live audience at
BioWest to a panel of bioscience experts and venture capitalists. The winner, announced at the end of the
conference day, will receive a $7,500 cash prize.
‐More‐

2. Page 2
About BioWest 2012
The conference features keynote speakers Ginger Graham of Harvard Business School and past president of
Amylin Pharmaceuticals and Mike Huckman former CNBC biopharma and medical device industry reporter‐
turned‐PR pro. The one‐day event is attended by more than 500 industry leaders, government
representatives, executives, researchers, investors and entrepreneurs. BioWest provides Colorado's bioscience
community opportunities to network, learn from one another and collaborate to grow the industry.
Conference Registration is now open at http://www.CoBioScience.com/BioWest. Early rates for members start
at $250 and $325 for non‐members and passes for the expo hall & reception only are $75 for members and
$125 for non‐members. Group rates are available for companies and organizations.
Registration for the conference also includes Conference Tracks with programs focusing on Business
Development and Clinical Trials; the Exhibit Hall with over 40 exhibitors showcase new technologies, products
and services to attendees; and the Poster Session featuring Boettcher Investigators in the Webb‐Waring
Biomedical Research Program to showcase earlier stage technologies from the region’s top research
institutions.
BioWest 2012 Sponsors include Founders Session Sponsor, Colorado Science + Technology Park at Fitzsimons;
Keynote Lunch Sponsor, Ernst & Young ; Venture Showcase Sponsors, Dorsey & Whitney LLP, EKS&H, Metro
Denver EDC;Track Sponsors, NextGen, Clinipace, Lonza, Sheridan Ross PC; Lanyard Sponsor, Cooley; Closing
Reception Sponsor, Wells Fargo; Co‐track Sponsors, University of Colorado Health, National Jewish Health
Advanced Diagnostic Laboratories, DaVita Clinical Research; and, General Conference Sponsors, Johnson &
Johnson, PhRMA and Fisher Scientific.
About Colorado BioScience Association
The CBSA is a not‐for‐profit organization providing services and support for Colorado's bioscience industry.
With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a
better business environment, growing the state's biotech workforce, fighting for policies that support a strong
bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more
information, visit http://www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter: http://www.twitter.com/COBioscience
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
News Feed: http://coloradobio.blogspot.com
YouTube Channel: http://www.youtube.com/COBioscience
Pinterest: http://pinterest.com/COBioscience
# # #
Contacts:
Mae Desaire, Director of Marketing, Colorado BioScience Association ‐ http://www.cobioscience.com –
720‐382‐5918, mdesaire@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations ‐ http://www.absolutelypr.com ‐ 303‐984‐9801,
maggie@absolutelypr.com